Your browser doesn't support javascript.
loading
Ribosomal protein S3 mediates drug resistance of proteasome inhibitor: potential therapeutic application in multiple myeloma.
Chen, Gege; Gao, Xuejie; Jia, Xinyan; Wang, Yingcong; Xu, Li; Yu, Dandan; Chang, Shuaikang; Deng, Hui; Hu, Ke; Wang, Guanli; Li, Bo; Xu, Zhijian; Lu, Yumeng; Wang, Huaping; Zhang, Ting; Song, Dongliang; Yang, Guang; Wu, Xiaosong; Zhu, Huabin; Zhu, Weiliang; Shi, Jumei.
Afiliación
  • Chen G; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120.
  • Gao X; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120.
  • Jia X; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120.
  • Wang Y; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072.
  • Xu L; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120.
  • Yu D; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072.
  • Chang S; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120.
  • Deng H; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120.
  • Hu K; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120.
  • Wang G; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120.
  • Li B; CAS Key Laboratory of Receptor Research; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203.
  • Xu Z; CAS Key Laboratory of Receptor Research; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203.
  • Lu Y; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072.
  • Wang H; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072.
  • Zhang T; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072.
  • Song D; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072.
  • Yang G; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072.
  • Wu X; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072.
  • Zhu H; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072.
  • Zhu W; CAS Key Laboratory of Receptor Research; State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203. wlzhu@simm.ac.cn.
  • Shi J; Department of Hematology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120. shijumei@tongji.edu.cn.
Haematologica ; 109(4): 1206-1219, 2024 Apr 01.
Article en En | MEDLINE | ID: mdl-37767568
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: FN-kappa B / Mieloma Múltiple Límite: Animals Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: FN-kappa B / Mieloma Múltiple Límite: Animals Idioma: En Año: 2024 Tipo del documento: Article